Axonal degeneration in Parkinson's disease: = Axonale Degeneration beim Parkinson Syndrom
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Erlangen ; Nürnberg
[2019]
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | 77, VII Seiten Illustrationen, Diagramme 21 cm |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV045552389 | ||
003 | DE-604 | ||
005 | 20190429 | ||
007 | t | ||
008 | 190410s2019 gw a||| m||| 00||| eng d | ||
015 | |a 19,H05 |2 dnb | ||
016 | 7 | |a 1182063799 |2 DE-101 | |
020 | |c Broschur | ||
035 | |a (OCoLC)1121487528 | ||
035 | |a (DE-599)DNB1182063799 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-29T |a DE-29 |a DE-355 | ||
084 | |a 610 |2 sdnb | ||
084 | |a 570 |2 sdnb | ||
100 | 1 | |a Grosch, Janina |e Verfasser |4 aut | |
245 | 1 | 0 | |a Axonal degeneration in Parkinson's disease |b = Axonale Degeneration beim Parkinson Syndrom |c vorgelegt von Janina Grosch (geb. Deußer) |
246 | 1 | 3 | |a Axonale Degeneration beim Parkinson Syndrom |
246 | 1 | 1 | |a Axonale Degeneration beim Parkinson Syndrom |
264 | 1 | |a Erlangen ; Nürnberg |c [2019] | |
300 | |a 77, VII Seiten |b Illustrationen, Diagramme |c 21 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Friedrich-Alexander-Universität Erlangen-Nürnberg |d 2019 | ||
610 | 2 | 7 | |a Serotonin |0 (DE-588)10071510-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Axon |0 (DE-588)4200576-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
689 | 0 | 1 | |a Axon |0 (DE-588)4200576-0 |D s |
689 | 0 | 2 | |a Serotonin |0 (DE-588)10071510-2 |D b |
689 | 0 | |5 DE-604 | |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u http://d-nb.info/1182063799/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030936339&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-030936339 |
Datensatz im Suchindex
_version_ | 1804179528224866304 |
---|---|
adam_text | CONTENTS
LIST
OF
FIGURES
......................................................................................
I
LIST
OF
TABLES
.......................................................................................
II
1
DECLARATION
........................................................................................
III
2
SUMMARY/ZUSAMMENFASSUNG
.........................................................
1
2.1
SUMMARY
..........................................................................................................
1
2.2
ZUSAMMENFASSUNG
........................................................................................
3
3
INTRODUCTION
.......................................................................................
5
3.1
PARKINSON
*
S
DISEASE
.......................................................................................
5
3.1.1
CLINIC
.........................................................................................................
5
3.1.2
EPIDEMIOLOGY
............................................................................................
5
3.1.3
THERAPY
.....................................................................................................
6
3.1.4
NEUROPATHOLOGY
.........................................................................................
6
3.1.5
PATHOGENESIS
............................................................................................
9
3.2
HUMAN
STEM
CELLS
........................................................................................
12
3.2.1
ADULT
NEUROGENESIS
.................................................................................
12
3.2.2 INDUCED
PLURIPOTENT
STEM
CELLS
................................................................
14
3.2.3
IPSC
MODELS
OF
PD
................................................................................
14
3.2.4
STEM
CELL
THERAPY
IN
NEURODEGENERATIVE
DISEASES
.................................
15
3.3
HYPOTHESIS
OF
THE
THESIS
...............................................................................
16
4
MATERIAL
.............................................................................................
18
4.1
CHEMICALS
.....................................................................................................
16
4.2
KITS
AND
MASTER
MIXES
..................................................................................
18
4.3
PROTEIN
STANDARDS
.........................................................................................
18
4.4
BUFFERS
AND
SOLUTIONS
....................................................................
18
4.5
CELL
CULTURE
MEDIA
........................................................................................
20
4.6
REAGENTS
AND
DISPOSABLES
..........................................................................
22
4.7
PRIMARY
ANTIBODIES
.......................................................................................
23
4.8
SECONDARY
ANTIBODIES
.................................................................................
24
4.9
TECHNICAL
DEVICES
........................................................................................
25
4.10
SOFTWARE
...................................
.
.......
26
5
METHODS
.................................................................
27
5.1
ANIMAL
EXPERIMENTS
......................................................................................
27
5.1.1
TRANSGENIC
MICE
......................................................................................
27
5.1.2
HISTOLOGY
AND
LIGHT
MICROSCOPY
............................................................... 27
5.1.3
HIGH
PRESSURE
LIQUID
CHROMATOGRAPHY
....................................................
28
5.1.4
PROTEIN
EXTRACTION
AND
WESTERN
BLOT
.......................................................29
5.2
CELL
CULTURE
....................................................................................................
29
5.2.1
GENERATION
OF
INDUCED
PLURIPOTENT
STEM
CELLS
........................................
29
5.2.2
MIDBRAIN
DIFFERENTIATION
USING
SMALL
MOLECULES
......................................
30
5.2.3
IMMUNOCYTOCHEMISTRY
.............................................................................
31
5.2.4 FLOW
CYTOMETRY
........................................................................................
31
5.2.5
ANALYSIS
OF
NEUNTE
MORPHOLOGY
..............................................................
31
5.2.6
LIFE
CELL
IMAGING
(AXONAL
TRANSPORT,
CALCIUM
IMAGING)
...........................
32
5.2.7
QUANTIFICATION
OF
MITOCHONDRIA
................................................................
34
5.2.8
QUANTIFICATION
OF
SYNAPSES
.....................................................................
34
5.2.9
RNA
EXTRACTION
...........................................................
34
5.2.10
REVERSE
TRANSCRIPTION
AND
REAL
TIME-POLYMERASE
CHAIN
REACTION
..........
34
5.3
STATISTICS
.........................................................................................................
35
6
RESULTS
..............................................................................................
36
6.1
IMPAIRED
SEROTONERGIC
SYSTEM
IN
THE
A53T
ALPHA-SYNUCLEIN
MOUSE
MODEL
OF
PD
.....................................................................................................................
36
6.1.1
EXPRESSION
OF
ALPHA-SYNUCLEIN
IN
BRAINSTEM
SEROTONERGIC
NEURONS
.......
37
6.1.2
SEROTONERGIC
NEURONS
ARE
NOT
REDUCED
IN
A53T
ALPHA-SYNUCLEIN
MICE
37
6.1.3
REDUCED
LEVELS
OF
SEROTONIN
IN
THE
BRAINSTEM
OF
A53T
ALPHA-SYNUCLEIN
MICE
..................................................................................................................
38
6.1.4
CHARACTERIZATION
OF
THE
SEROTONERGIC
INNERVATION
INTO
THE
HIPPOCAMPAL
FORMATION
...........................................................................................................
38
6.1.5
ALPHA-SYNUCLEIN
IS
PRESENT
IN
HIPPOCAMPAL
SEROTONERGIC
FIBERS
.............40
6.1.6
REDUCED
SEROTONERGIC
INNERVATION
OF
THE
DORSAL
DG
.............................
40
6.1.7
SERT
EXPRESS
IO
N
IN
THE
BRAIN
STEM
OF
TRANSGENIC
MICE
........................
41
6.1.8
REDUCED
RESPONSE
TO
FLUOXETINE
TREATMENT
IN
TRANSGENIC
MICE
........... 42
6.2
STRUCTURAL
AND
FUNCTIONAL
ANALYSIS
OF
NEUNTES
IN
SPORADIC
PD
PATIENTS-
DERIVED
NEURONS
..........................
44
6.2.1
CHARACTERIZATION
OF
SPORADIC
PD
PATIENT-DERIVED
IPSC
......................... 44
6.2.2
GENERATION
AND
CHARACTERIZATION
OF
NEURAL
PROGENITOR
CELLS
..................
47
6.2.3
NEURONAL
DIFFERENTIATION
POTENTIAL
OF
CTRL
AND
PD-DERIVED
NPCS
.........
47
6.2.4
REDUCED
NEU
RITE
LENGTH
IN
PD
PATIENT-DERIVED
MIDBRAIN
NEURONS
.......
50
6.2.5
AXONAL
TRANSPORT
OF
MITOCHONDRIA
IN
CTRL-
AND
PD-DERIVED
LINES
..........
51
6.2.6
DISTRIBUTION
OF
MITOCHONDRIA
ALONG
AXONS
IN
CTRL-
AND
PD-DERIVED
LINES
52
6.2.7
CTRL-
AND
PD-DERIVED
NEURONS
FORM
SYNAPTIC
CONTACTS
.........................
53
6.2.8
SPONTANEOUS
ACTIVITY
AND
EXCITABILITY
OF
IPSC-DERIVED
NEURONS
...........
54
7
DISCUSSION
.......................................................................................
56
7.1
AXONAL
DEGENERATION
PRECEDES
LOSS
OF
SEROTONERGIC
RAPHE
NEURONS
IN
TRANSGENIC
MODELS
OF
PD
....................................................................................
56
7.2
A
POSSIBLE
LINK
BETWEEN
LOSS
OF
SEROTONERGIC
INNERVATION
INTO
THE
HIPPOCAMPAL
NEUROGENIC
NICHE
AND
NMS
IN
PD
............................................. 57
7.3
EARLY
AXONAL
DEGENERATION
-
THE
ROLE
OF
IMPAIRED
AXONAL
TRANSPORT
........
61
7.4
IPSC
MODELS
OF
PARKINSON
*
DISEASE
..........................................................
63
7.5
CHALLENGES
OF
MODELING
SPORADIC
PD
.........................................................
66
7.6
CONCLUSIONS
..................................................................................................
67
8
BIBLIOGRAPHY
....................................................................................
69
9
ABBREVIATIONS
....................................................................................
IV
10
ACKNOWLEDGEMENTS
.......................................................................
VI
|
any_adam_object | 1 |
author | Grosch, Janina |
author_facet | Grosch, Janina |
author_role | aut |
author_sort | Grosch, Janina |
author_variant | j g jg |
building | Verbundindex |
bvnumber | BV045552389 |
ctrlnum | (OCoLC)1121487528 (DE-599)DNB1182063799 |
discipline | Biologie Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01916nam a2200469 c 4500</leader><controlfield tag="001">BV045552389</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190429 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">190410s2019 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,H05</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1182063799</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1121487528</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1182063799</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">570</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grosch, Janina</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Axonal degeneration in Parkinson's disease</subfield><subfield code="b">= Axonale Degeneration beim Parkinson Syndrom</subfield><subfield code="c">vorgelegt von Janina Grosch (geb. Deußer)</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Axonale Degeneration beim Parkinson Syndrom</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Axonale Degeneration beim Parkinson Syndrom</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">77, VII Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="d">2019</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Serotonin</subfield><subfield code="0">(DE-588)10071510-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Axon</subfield><subfield code="0">(DE-588)4200576-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Axon</subfield><subfield code="0">(DE-588)4200576-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Serotonin</subfield><subfield code="0">(DE-588)10071510-2</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1182063799/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030936339&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030936339</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV045552389 |
illustrated | Illustrated |
indexdate | 2024-07-10T08:21:18Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030936339 |
oclc_num | 1121487528 |
open_access_boolean | |
owner | DE-29T DE-29 DE-355 DE-BY-UBR |
owner_facet | DE-29T DE-29 DE-355 DE-BY-UBR |
physical | 77, VII Seiten Illustrationen, Diagramme 21 cm |
publishDate | 2019 |
publishDateSearch | 2019 |
publishDateSort | 2019 |
record_format | marc |
spelling | Grosch, Janina Verfasser aut Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom vorgelegt von Janina Grosch (geb. Deußer) Axonale Degeneration beim Parkinson Syndrom Erlangen ; Nürnberg [2019] 77, VII Seiten Illustrationen, Diagramme 21 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Friedrich-Alexander-Universität Erlangen-Nürnberg 2019 Serotonin (DE-588)10071510-2 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf Axon (DE-588)4200576-0 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Parkinson-Krankheit (DE-588)4044683-9 s Axon (DE-588)4200576-0 s Serotonin (DE-588)10071510-2 b DE-604 B:DE-101 application/pdf http://d-nb.info/1182063799/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030936339&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Grosch, Janina Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom Serotonin (DE-588)10071510-2 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd Axon (DE-588)4200576-0 gnd |
subject_GND | (DE-588)10071510-2 (DE-588)4044683-9 (DE-588)4200576-0 (DE-588)4113937-9 |
title | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom |
title_alt | Axonale Degeneration beim Parkinson Syndrom |
title_auth | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom |
title_exact_search | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom |
title_full | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom vorgelegt von Janina Grosch (geb. Deußer) |
title_fullStr | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom vorgelegt von Janina Grosch (geb. Deußer) |
title_full_unstemmed | Axonal degeneration in Parkinson's disease = Axonale Degeneration beim Parkinson Syndrom vorgelegt von Janina Grosch (geb. Deußer) |
title_short | Axonal degeneration in Parkinson's disease |
title_sort | axonal degeneration in parkinson s disease axonale degeneration beim parkinson syndrom |
title_sub | = Axonale Degeneration beim Parkinson Syndrom |
topic | Serotonin (DE-588)10071510-2 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd Axon (DE-588)4200576-0 gnd |
topic_facet | Serotonin Parkinson-Krankheit Axon Hochschulschrift |
url | http://d-nb.info/1182063799/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030936339&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT groschjanina axonaldegenerationinparkinsonsdiseaseaxonaledegenerationbeimparkinsonsyndrom AT groschjanina axonaledegenerationbeimparkinsonsyndrom |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis